Catalyst Pharmaceuticals, Inc. (CPRX)
24.24
-0.08
(-0.33%)
USD |
NASDAQ |
Mar 06, 16:00
24.35
+0.11
(+0.45%)
After-Hours: 20:00
Catalyst Pharmaceuticals SG&A Expense (TTM) : 171.18M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| Karyopharm Therapeutics, Inc. | 105.21M |
| Krystal Biotech, Inc. | 146.91M |
| Replimune Group, Inc. | 103.07M |